Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Livedoid Vasculopathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00841594
What this trial is testing

MQX-503 Applied to the Hand Versus Nitroglycerin Ointment Applied to the Chest: A Pharmacokinetic Comparison

Who this might be right for
Raynaud's Phenomenon
MediQuest Therapeutics 12
Not applicableWithdrawnNCT04898036
What this trial is testing

Phototherapy For Treatment Of Raynaud's Phenomenon

Who this might be right for
Raynaud DiseaseRaynaud PhenomenonRaynaud Syndrome
University of Minnesota
Testing effectiveness (Phase 2)Study completedNCT00707187
What this trial is testing

Trial of IC351 in Female Scleroderma Patients With Raynaud's and Sexual Dysfunction

Who this might be right for
Systemic Sclerosis
University of Medicine and Dentistry of New Jersey 120
Not applicableLooking for participantsNCT06675344
What this trial is testing

The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life

Who this might be right for
Systemic Sclerosis (SSc)
Robyn T. Domsic, MD, MPH 160
Testing effectiveness (Phase 2)Study completedNCT01090492
What this trial is testing

PF-00489791 For The Treatment Of Raynaud's

Who this might be right for
Raynaud's DiseasePeripheral Vascular Disease
Pfizer 243
Not applicableUnknownNCT03972566
What this trial is testing

Localized Effects of PBM and Exogenous NO on CREST Patients Calcinosis Cutis & Raynaud Phenomenon

Who this might be right for
CREST SyndromeCalcinosis CutisRaynaud Phenomenon
RoseLab Skin Optics Laboratory 5
Not applicableStudy completedNCT02396238
What this trial is testing

Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells (STAR)

Who this might be right for
SclerodermaSystemic SclerosisRaynaud Phenomena+1 more
Cytori Therapeutics 88
Large-scale testing (Phase 3)Not Yet RecruitingNCT05698979
What this trial is testing

Evaluation of Botulinum TOXin Type A in the Treatment of Buerger's Disease

Who this might be right for
Buerger DiseaseRaynaud Syndrome
University Hospital, Toulouse 8
Not applicableLooking for participantsNCT06989216
What this trial is testing

Multi-modal Quantitative Imaging of the Skin

Who this might be right for
Skin CancerSkin DiseasesAtopic Dermatitis+4 more
HJN Sverige AB/Neko Health 8,000
Large-scale testing (Phase 3)UnknownNCT00577304
What this trial is testing

A Topical Form of Nitroglycerin and Placebo in the Treatment and Prevention of Raynaud's Phenomenon

Who this might be right for
Raynaud's DiseaseRaynaud's Disease Secondary to SclerodermaRaynaud's Disease Secondary to Other Autoimmune Disease
MediQuest Therapeutics 200
Post-approval studies (Phase 4)Ended earlyNCT03639766
What this trial is testing

The Effect of Abobotulinum Toxin A on the Symptoms of Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
University of Central Florida 3
Not applicableStudy completedNCT02683408
What this trial is testing

Diosmiplex (Vasculera®) in Primary and Secondary Raynaud's Phenomenon

Who this might be right for
Raynaud's Disease
Primus Pharmaceuticals 87
Post-approval studies (Phase 4)Study completedNCT00048776
What this trial is testing

Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon

Who this might be right for
Raynaud's Disease
Otsuka America Pharmaceutical 75
Large-scale testing (Phase 3)Study completedNCT02165111
What this trial is testing

Efficacy of Botulinum Toxin In Scleroderma-Associated Raynaud's Syndrome

Who this might be right for
SclerodermaRaynaud's Syndrome
Johns Hopkins University 40
Testing effectiveness (Phase 2)Study completedNCT00480753
What this trial is testing

Dose Response Study of a Topical Formulation of Nitroglycerin for the Treatment of Raynaud's Phenomenon

Who this might be right for
Raynaud's Disease
MediQuest Therapeutics 15
Not applicableStudy completedNCT03211325
What this trial is testing

Identification of TRP Channels as New Potential Therapeutic Targets in Primary and Secondary Raynaud's Phenomenon.

Who this might be right for
Raynaud's Phenomenon Isolated PrimaryRaynaud's Phenomenon (Secondary)Healthy
University Hospital, Grenoble 29
Testing effectiveness (Phase 2)Study completedNCT00528242
What this trial is testing

Safety, Tolerability, and Pharmacodynamic Profile of Oral 2101 in Secondary Raynaud's Disease

Who this might be right for
Raynaud's Disease
Response Pharmaceuticals 17
Not applicableStudy completedNCT03129178
What this trial is testing

Beet the Cold: The Effect of Inorganic Nitrate Supplementation in Individuals With Raynaud's Phenomenon

Who this might be right for
Raynaud Phenomenon
University of Portsmouth 27
Large-scale testing (Phase 3)Study completedNCT01117298
What this trial is testing

Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma

Who this might be right for
Raynaud's PhenomenonDigital UlcersScleroderma
Sanjay Gandhi Postgraduate Institute of Medical Sciences 66
Not applicableStudy completedNCT05878327
What this trial is testing

Livedoid Vasculopathy: Strong Association With Smoking, Weak Association With Thrombophilia

Who this might be right for
Livedoid Vasculitis
University of Zurich 15
Next Page